# To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup

> **NCT02593747** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 54 (actual)

## Conditions studied

- Histamine H1 Antagonists, Non-Sedating

## Interventions

- **DRUG:** Loratadine oral solution
- **DRUG:** Loratadine (Claritin peach syrup)

## Key facts

- **NCT ID:** NCT02593747
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-01
- **Final completion:** 2016-03
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2017-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02593747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02593747, "To Assess Bioequivalence of Loratadine Oral Solution/Syrup Versus Claritin Peach Syrup". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02593747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*